GLOBUS MEDICAL INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 09/30/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.9B | $2.5B | $1.6B | $1.0B | — |
| Cost of revenue | $957.8M | $1.0B | $548.2M | $263.7M | — |
| Gross profit | — | — | $1.0B | $759.1M | — |
| Selling, general & administrative | $1.2B | $981.4M | $643.8M | $432.1M | — |
| Research and development | $147.2M | $163.8M | $124.0M | $73.0M | — |
| Operating expenses | — | — | $887.2M | $531.2M | — |
| Operating income | $479.8M | $166.0M | $133.1M | $228.0M | — |
| Pretax income | $605.1M | $120.7M | $165.4M | $243.0M | — |
| Income tax expense | $67.2M | $17.7M | $42.5M | $52.9M | — |
| Net income | $537.9M | $103.0M | $122.9M | $190.2M | — |
| Balance Sheet | |||||
| Cash and equivalents | $526.2M | $784.4M | — | — | — |
| Current assets | $2.1B | $2.2B | $1.9B | $983.3M | — |
| Total assets | $5.3B | $5.3B | $5.1B | $2.1B | — |
| Current liabilities | $498.5M | $855.9M | $392.3M | $159.2M | — |
| Total liabilities | $729.5M | $1.1B | $1.1B | $229.8M | — |
| Stockholders' equity | $4.6B | $4.2B | $4.0B | $1.8B | $1.8B |
| Cash Flow Statement | |||||
| Cash from operations | $753.4M | $520.6M | $243.5M | $178.5M | — |
| Depreciation and amortization | $276.8M | $253.4M | $145.5M | $68.3M | — |
| Stock-based compensation | $49.8M | $54.2M | $52.7M | $32.8M | — |
| Capital expenditure | $164.7M | $115.4M | $78.3M | $74.0M | — |
| Free cash flow | $588.8M | $405.2M | $165.2M | $104.4M | — |
| Share repurchases | $300.5M | $85.8M | $225.6M | $144.5M | — |
| Impairments | $0 | $0 | $0 | $0 | — |
Shares outstanding 135.7M · Free float 81.6%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.